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chronic irradiation of human 
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Over the past decades, there have been huge advances in understanding cellular responses to ionising 
radiation (IR) and DNA damage. These studies, however, were mostly executed with cell lines and 
mice using single or multiple acute doses of radiation. Hence, relatively little is known about how 
continuous exposure to low dose ionising radiation affects normal cells and organisms, even though 
our cells are constantly exposed to low levels of radiation. We addressed this issue by examining the 
consequences of exposing human primary cells to continuous ionising γ-radiation delivered at 6–20 
mGy/h. Although these dose rates are estimated to inflict fewer than a single DNA double-strand break 
(DSB) per hour per cell, they still caused dose-dependent reductions in cell proliferation and increased 
cellular senescence. We concomitantly observed histone protein levels to reduce by up to 40%, which 
in contrast to previous observations, was not mainly due to protein degradation but instead correlated 
with reduced histone gene expression. Histone reductions were accompanied by enlarged nuclear 
size paralleled by an increase in global transcription, including that of pro-inflammatory genes. Thus, 
chronic irradiation, even at low dose-rates, can induce cell senescence and alter gene expression via a 
hitherto uncharacterised epigenetic route. these features of chronic radiation represent a new aspect of 
radiation biology.
The detrimental effects of ionising radiation (IR) on health were observed within a few years of the discovery 
of X-rays. The link between IR exposure and eventual development of cancer nurtured much research into the 
mechanisms by which this occurs. Experiments carried out mainly with mice and cell lines uncovered the ability 
of IR to damage DNA, suggesting that occasional mistakes introduced during DNA repair result in mutations 
that can drive cells into carcinogenic paths. Several lines of evidence suggest that radiation may also impose 
biological effects through non-mutational routes, such as the association between radiation and pathologies that 
do not appear to be initiated or promoted by accumulation of mutations, such as cardiovascular disease1–4 and 
cataract formation5, possibly via damage and changes to cellular structures and proteins. Unfortunately, the pace 
of research in this area has been modest, in part due to the lack of an apparent non-mutational mechanism that 
could explain the impacts of radiation on these non-cancer diseases.
Another area that remains largely unexplored is the biological consequences of continuous exposure to low 
doses of radiation. The majority of this comes from natural sources such as radon gas, terrestrial radiation and 
cosmic rays that penetrate the Earth’s atmosphere. An average person will receive approximately 2.4 mGy per 
year6, yet this varies over 10-fold in different geographical locations worldwide7. Although the health impacts of 
chronic radiation have been questioned from the early days of radiation research, relatively few studies have been 
carried out. Whether continuous low-level IR would generate proportionally low levels of DNA damage, and 
whether the repair of these small numbers of lesions incurs proportionally low rates of mutagenesis, are ques-
tions that remain to be fully addressed. While it may appear reasonable that risk would have a linear relationship 
with radiation dose, this has proven to be contentious because experiments have produced equivocal evidence. 
Various studies suggest that low doses of radiation pose lower8,9, predicted10,11 or higher12,13 risk than expected 
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based on the widely assumed model that there is a linear relationship between dose and risk. It is impossible to 
ascertain which of these is correct because the number of reported studies is low, and they come from a wide 
range of experimental sources, which do not lend themselves to direct comparison. Furthermore, conceptual 
extrapolation of our understanding of DNA damage signalling induced by high and acute doses of radiation may 
be incorrect, as DNA damage inflicted by low-dose chronic radiation is very different. It is unclear whether there 
is a threshold of DNA damage that must be breached for cells to respond, and whether continuous and consecu-
tive DNA damage will be tolerated or ignored by the cell. As it has been suggested that persistent DNA-damage 
signalling can drive cells into senescence14, it may be that repeated, albeit low levels of, DNA damage from chronic 
radiation prevents complete diminution of DNA damage signals below a theoretical minimum level or interval, 
thereby causing cells to initiate and progress into a senescent state. There is increasing appreciation of the impor-
tance of these issues because of the growing use of medical procedures such as computed tomography (CT), 
which can give more than an average year’s total radiation dose in a single scan15. However, the experimental 
model, endpoint and risk measure will always be critical to this assessment.
Outside the field of radiobiology, attention is increasingly drawn to the importance of non-genetic changes 
in cancer and non-cancer pathologies. These changes include those mediated by modifications of DNA (such 
as methylation), as well as modifications of histones at multiple positions (including phosphorylation, methyl-
ation and acetylation) and other DNA-binding proteins, and changes in expression of non-coding RNAs; all of 
which can regulate chromatin state and gene expression16,17. Thus, radiation can contribute to pathologies that 
are not dependent on mutations, through epigenetic alterations. Indeed, we have previously demonstrated that 
the CD44 gene promoter is de-methylated following irradiation, resulting in over-expression and presentation 
of this highly adhesive protein on the apical membrane of endothelial cells, increasing the risk of atherosclerotic 
plaque development18. Indeed, it is now clear that radiation can lead to histone modifications19–21, a key paradigm 
for which being the well-documented effect of IR on the H2A histone variant, H2AX (H2AFX). When DNA is 
damaged by radiation or alternative causes to yield double-strand breaks (DSBs), H2AX becomes phosphorylated 
on its C-terminal tail at serine 139 and is known as γH2AX22,23. This occurs at and on the chromatin flanking the 
DSB sites20. H2AX phosphorylation in response to DSBs is carried out by the protein kinase ATM in addition 
to other phosphatidylinositol 3-kinase like kinases ATR and DNA-PK24. γH2AX then triggers the recruitment 
of other cellular proteins to mediate a DNA damage response (DDR), which involves activation of DNA repair 
mechanisms as well as intracellular signalling processes that impact on various aspects of cell physiology and can 
lead to temporary cell cycle slowing or arrest, long term cell cycle arrest and/or cell senescence or programmed 
cell death. The key roles of this histone mark are demonstrated by reduced survival of H2AX−/− mice follow-
ing whole body irradiation25 and increased chromosomal aberrations in their embryonic stem cells26. Other 
histone-related responses to radiation include ubiquitylation of histones H2A and H2B27,28, several modifications 
on histones H3 and H419, localised removal of H2A.Z (H2AFZ)29–32, augmented levels of histone H2A.J (H2AFJ) 
and subsequent epigenetic augmentation of inflammatory gene expression33.
Here, we describe studies in which we have continuously exposed primary cells isolated from human skin to 
ionising γ-radiation. We report that radiation exposures estimated to inflict fewer than one DSB per hour per 
cell, decreased cell proliferation and increased cellular senescence. Moreover, we document that these senescent 
cell populations display a reduction in histone levels and a concomitant increase in nuclear size and global gene 
expression. We show that these changes are associated with pronounced changes in gene expression, causing 
alterations in protein expression, some of which are pro-inflammatory and reflect an aged-cell phenotype. We 
discuss how the long-term presence of senescent cells harbouring these features in irradiated tissues might com-
prise a pathological route by which IR imposes its effects on health.
Materials and Methods
Isolation, culture and treatment of primary cells. Primary cells were isolated from human neonatal 
foreskin removed for routine circumcision, or adult facial skin following minor dermatology procedures. Tissue 
was transported the same day and digested overnight at 4 °C with 0.5 mg/ml liberase DH (Roche, 5401089001) in 
Epidermal Keratinocyte Medium (CellnTech, CnT-07). The following day, the epidermis was removed using sterile 
instruments and then pressed in trypsin-EDTA to form a single cell suspension, pelleted and resuspended in kerat-
inocyte medium (CnT-07). Cells were seeded on collagen/fibronectin coated flasks for keratinocyte isolation. To 
isolate fibroblasts, dermal pieces were grown in DMEM supplemented with 10% FBS (Gibco) and grown as explants. 
Remaining dermal tissue was digested in 2.5 mg/ml collagenase in HBSS (with added calcium and magnesium) 
at 37 °C with frequent agitation for 1 h, passed through a 70 μm cell strainer and selected using CD31 magnetic 
Dynabead positive selection (Life Technologies, 11155D) and seeded on a gelatin-coated flask in Endothelial Cell 
Growth Medium MV (PromoCell, C-22020). Transport and initial isolation were carried out with double concen-
tration of antibiotics, followed by 7 days in normal concentration (100 U penicillin, 0.1 mg streptomycin, 10 µg gen-
tamycin and 0.25 μg amphotericin B per ml); routine culture and experiments were carried out without antibiotics. 
Cells were passed by washing with HBSS and trypsinisation, followed by soybean trypsin inhibitor and resuspension 
in the appropriate medium and seeded at 1:3–1:5 ratio with coating used for initial isolation.
The human cell line RPE-1 (SNP6 verified, from Professor J. Pines - The Institute of Cancer Research, London) 
was used to generate CRISPR-Cas9 induced clonal knock-outs of p53 and ATM as described previously34,35. Cells 
were grown in DMEM/F12 Ham (Sigma, D6421) supplemented with 10% FBS, pen/strep, glutamine and sodium 
bicarbonate. RPE-1 knockout cultures were exposed to chronic IR alongside puromycin resistance knockout 
(wild type) controls.
exposure to iR. Cells were chronically irradiated by exposure to a gamma-emitting Cs-137 source in a 
custom-built irradiator (Gemini Technologies) at 37 °C, 5% CO2, high humidity and under constant exposure to 
low levels of IR except when removed for routine media change. Unirradiated controls were cultured in identical 
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culture conditions without IR. Dose rates of 6–20 mGy/h were achieved by using lead filters and variable dis-
tances from the source. Unless otherwise stated, cells were chronically irradiated for 7 days. For acute irradiation, 
cells were exposed to X-rays in an AGO X-ray System (CP/1601) with 250 kV, 13 mA and 60 cm from the source, 
giving a dose rate of 0.5 Gy/min.
Assays for cellular responses to iR. Apoptosis was quantified using Caspase-Glo 3/7 luminescence assay 
(Promega, G8091). Senescence staining was carried out using SA-β-Galactosidase Staining Kit (Cell Signalling 
Technologies, 9680) and quantified using Galacto-Light Plus Beta-Galactosidase Reporter Gene Assay System 
(Invitrogen, T1007) following the manufacturer’s protocol, except modified to use lysosomal reaction buffer 
(100 mM sodium phosphate pH 6, 20 μM MgCl2).
Indirect immunofluorescence analyses. Cells grown on collagen/fibronectin coated coverslips were 
fixed with formalin for 15 minutes, permeabilised with 0.1% Triton X-100, blocked with 2% FBS/HBSS and incu-
bated with primary antibody for 1 h followed by washing and Alexa-conjugated secondary incubation, further 
washes, nuclear staining with 1 ug/ml DAPI and mounting. See Table 1 for list of antibodies used.
Quantification of DSBs. Following standard immunofluorescence staining of 53BP1, discreet foci (used 
as a surrogate for DSBs) were quantified per cell using fluorescence microscopy. Samples were scored blind in a 
minimum of 200 cells per radiation condition.
cellular drug treatments. To investigate protein degradation, proteasome was inhibited with 5 μM MG132 
(Sigma, M7449) or lysosomal autophagy inhibited with 10 μM chloroquine (Sigma, C6628) for 24 h. For kinase 
inhibition experiments, ATM was inhibited with 10 μM Ku55933 (Selleck, S1092) and ATR was inhibited with 
1–10 uM VE-821 (Selleck, S8007) for the duration indicated. Apoptosis was induced with 1 μM staurosporine 
(Enzo Life Sciences, ALX-380-014) for 4–6 hours. ROS was inhibited using 2 mM N-acetyl-L-cysteine (NAC) for 
the duration of the experiment (7 days).
Protein analysis by western blotting. Cells were harvested by washing cell monolayers twice with cold 
HBSS, scraped into a 1.5 ml tube, centrifuged and the pellet resuspended in HBSS containing Halt phosphatase 
and protease inhibitors (Thermo Scientific, 78429) then lysed with 1% SDS in 50 mM Tris pH 8.0. DNA was 
fragmented using Qiashredder (Qiagen, 79656) and protein concentration quantified using BCA assay (Thermo 
Scientific Pierce, 10056623 and 10475944) and measuring absorbance at 562 nm. Equal protein amounts were run 
on a polyacrylamide gel at 100 V for 1.5–2 h before transferring to PVDF membrane at 2.5 A, 25 V for 7 minutes 
using TransBlot Turbo (Bio-Rad). Membranes were blocked in 5% non-fat milk in TBS-T then incubated over-
night with primary antibodies (Table 1), washed three times with TBS-T, incubated for 1 h with HRP conjugated 
secondary antibody washed three times with TBS-T and exposed to X-ray film after ECL incubation (Immobilon 
Western HRP Substrate Reagent/Peroxide Substrate, Millipore, WBKLS0500). All antibody incubations were car-
ried out in 5% non-fat milk in TBS-T.
Supplier Cat. No. Application Dilution
53BP1 Millipore MAB3802 IF 1:200
ATM Abcam ab32420 WB 1:5000
ATM-P (S1981) Abcam ab81292 WB 1:5000
Chk1-P (S345) Cell Signalling 2348 WB 1:1000
GAPDH Santa Cruz sc-25778 WB 1:10000
H2A.J Active Motif 61793 WB 1:1000
H2AX Bethyl Lab A300-082A WB 1:5000
γH2AX Cell Signalling 9718S IF/WB 1:200/1:5000
Histone H1 Santa Cruz sc-8030 WB 1:500
Histone H2A Abcam ab18255 WB 1:2000
Histone H2A.Z Abcam ab150402 WB 1:1000
Histone H2B Abcam ab1790 WB 1:20000
Histone H3 Novus Biologicals NB500-171 WB 1:20000
Histone H4 Novus Biologicals NBP2-16848 WB 1:10000
Lamin B1 Abcam ab16048 WB 1:5000
p21 Abcam ab18209 WB 1:5000
p53 Santa Cruz sc-126 WB 1:10000
p53-P (S6) Cell Signalling 9285 WB 1:1000
p53-P (S15) Cell Signalling 9284 WB 1:1000
p53-P (S46) Cell Signalling 2521 WB 1:1000
Table 1. List of antibodies used. IF = Immunofluorescence; WB = Western Blot.
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MS sample preparation. For SILAC (stable isotope labelling of amino acids in cell culture) experiments, 
primary fibroblasts were grown in heavy (R10K8), light (R6K4) or unlabelled SILAC DMEM (Dundee Cell 
Products) for 8–10 population doublings then exposed to 0, 6 or 20 mGy/h for 7 days. Cell pellets were collected, 
lysed with LDS buffer supplemented with 1 mM DTT, heated at 70 degrees for 10 min. Samples were then quan-
tified and pooled in mixed combinations to provide triplicate samples. Proteins were alkylated by the addition of 
5.5 mM chloroacetamide for 30 min and resolved on 4–12% gradient SDS-PAGE gels (NuPAGE Bis-Tris Precast 
Gels, Life Technologies). The gels were stained using the Colloidal Blue Staining Kit (Life Technologies) and 
proteins were digested in-gel using trypsin. Peptides were extracted from gel and desalted on reversed-phase C18 
StageTips36.
MS analysis. Peptide fractions were analysed on a quadrupole Orbitrap mass spectrometer (Q Exactive Plus, 
Thermo Scientific) equipped with a UHPLC system (EASY-nLC 1000, Thermo Scientific)37. Peptide samples were 
loaded onto C18 reversed phase columns (15 cm length, 75 μm inner diameter, 1.9 μm bead size) and eluted 
with a linear gradient from 5 to 30% acetonitrile containing 0.1% formic acid in 3 h. The mass spectrometer was 
operated in data dependent mode, automatically switching between MS and MS2 acquisition. Survey full-scanMS 
spectra (m/z 300–1700) were acquired in the Orbitrap. The ten most intense ions were sequentially isolated and 
fragmented by higher energy C-trap dissociation (HCD)38. Peptides with unassigned charge states, as well as with 
charge states less than +2 were excluded from fragmentation. Fragment spectra were acquired in the Orbitrap 
mass analyser.
Peptide identification. Raw data files were analyzed using MaxQuant (development version 1.5.2.8)39. 
Parent ion and MS2 spectra were searched against a database containing 92,578 human protein sequences 
obtained from the UniProtKB released in December 2016 using Andromeda search engine40. Spectra were 
searched with a mass tolerance of 6 ppm in MS mode, 20 ppm in HCD MS2 mode, strict trypsin specificity 
and allowing up to two missed-cleavages. Cysteine carbamidomethylation was searched as a fixed modification, 
whereas protein N-terminal acetylation and methionine oxidation were searched as variable modifications. The 
dataset was filtered based on posterior error probability to arrive at a false discovery rate below 1% estimated 
using a target-decoy approach41.
RNA-seq differential gene expression. RNA was extracted (Direct-zol, Zymo). Quality and concen-
tration were tested using (RNA BR assay kit, Quabit) both following the manufacturer’s protocol. 50 ug of RNA 
was used for whole transcriptome Illumina Hi-seq. 4000_150PE sequencing. Paired-end sequencing reads were 
aligned to the human genome hg1 using Tophat. Bam files from the same sample sequenced across different lanes 
were merged using Samtools merge. Features were counted with HTSeq. QC and differential gene expression 
analysis was carried out.
qRt-pcR gene expression analysis. RNA was extracted using the RNeasy Mini Kit, QIAshredder and 
RNase-free DNase set (all Qiagen) according to the manufacturer’s protocol and eluted in 30 μl RNase free water. 
RNA was quantified using Nanodrop spectrophotometric analysis (Labtech) measuring absorbance at 260 nm; 
260/280 and 260/230 ratios were monitored to indicate sample purity. 1000 ng RNA was reverse transcribed to 
cDNA using High Capacity RT kit (AB Bioscience). In triplicate, 10 μl of PCR reaction mix (1 μl sample cDNA, 
5 μl PerfeCTa SYBR Green Supermix (Quanta Biosciences), 0.3 μl of each F and R primers (3.3 μM) and 3.4 μl 
nuclease free water) was transferred to a 100-well rotor along with ‘no reverse transcription’ and ‘no transcript’ 
controls, and run on a Rotor Gene Q PCR machine for: 95 °C for 2 minutes, 40 cycles of 95 °C for 10 seconds then 
60 °C for 60 seconds, followed by a melt from 65 °C to 95 °C in 1 °C intervals; with optimisation before the first 
acquisition and channel was set to green. Ct values were normalised to the housekeeping gene HPRT and com-
pared between irradiated and control samples to give an average fold change by calculating 2−ΔΔCt.
Detection of reactive oxygen species. To detect cellular ROS, we used a DCFDA/H2DCFDA ROS Assay 
Kit (Abcam, ab113851), following manufacturer’s instructions. For both plate reader measurement, 50,000 cells 
were seeded in triplicate in a 96 well plate 24 hours prior to analysis of fluorescence. For flow cytometry anal-
ysis, cells were incubated with the dye during incubation with or without chronic radiation, trypsinised and 
1000 low-PI gated cells measured to establish mean fluorescence within the population. Cells were treated with 
200 mM tert-butyl hydroperoxide for 1 hour as a positive control.
Analysis of nuclear area and RnA synthesis. To measure nuclear area, cell monolayers were chronically 
irradiated as described and when almost confluent stained with 1 μg/ml DAPI (Sigma, D8417). Nuclei from a 
minimum of 200 cells or 5 fields were automatically detected and mean nuclear area calculated. Global RNA 
synthesis was measured using 2 h pulse labelling with Alexa 488-labelled EU and detected using RNA Click-IT 
HCS kit (C10327, Invitrogen) following the manufacturer’s protocol and quantified by automatic detection and 
intensity measurement using Nikon Eclipse Ti fluorescent microscope and Elements software. Box plots were 
generated using BoxPlotR (http://shiny.chemgrid.org/boxplotr/).
ethical approval and informed consent. Informed consent was obtained prior to collection of human 
skin samples with approval by the Oxford Research Ethics Committee; reference 10/H0605/1. All experiments 
were performed in accordance with relevant guidelines and regulations.
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Results
A confounding factor in experimental biology is the use of cell lines, the majority of which harbour known and 
unknown mutations and/or chromosomal rearrangements, amplifications and aneuploidies. Thus, this limits a 
researcher’s ability to accurately generalise observations made using them. Another factor that limits such gener-
alisations is the intrinsic differences between cell types and cell lines in regard to how they respond to challenges 
such as radiation. While it is impossible to test all cell types that constitute the body, we have endeavoured to do 
so for a limited number of primary, non-transformed cell types in most of the experiments described herein. To 
this end, we established and optimised the isolation and culture of keratinocytes, fibroblasts and microvascular 
endothelial cells from neonatal foreskins. While most of the experiments below were carried out with human pri-
mary fibroblasts, many of them were also replicated with the other cell types and from multiple donors, thereby 
greatly reducing the potential for donor-specific influences.
Low dose rates of chronic radiation inhibit cell proliferation. We exposed primary keratinocytes and 
fibroblasts to chronic γ-radiation at dose rates ranging from 6 mGy/h to 20 mGy/h for 7 days; doses predicted to 
produce relatively low numbers of DNA double-strand breaks (Fig. 1a). As a case in point, γ-radiation delivered 
at 20 mGy/hr is estimated to inflict fewer than one DSB per cell per hour. These predictions were in line with 
our experimental quantification of numbers of TP53-binding protein 1 (53BP1) foci, each of which represents 
the protein’s accumulation at a DSB site (Fig. 1b). Despite the small numbers of DSBs, these doses of radiation 
clearly impeded cell proliferation in a dose-dependent manner (Fig. 1c). This likely reflects a combination of cell 
Figure 1. Chronic low dose γ-radiation retards cell growth and induces cell responses to DNA damage. (a) 
Dose rates used for chronic γ-radiation exposures, corresponding cumulative doses over a 7-day period and 
DSB estimates based on 1 Gy generating 40 DSBs in a human cell (Olive, 1998). (b) Quantification of DSBs 
by immunofluorescence staining of 53BP1 foci in primary fibroblasts exposed to chronic radiation for 7 
days (>200 cells measured per condition, displayed as blue circles). Mean numbers of foci per cell are shown 
by crosses, and Tukey analyses are shown by boxes. (c) Proliferation rates of fibroblasts exposed to various 
dose-rates of chronic γ-radiation, data shown as triplicate measurements of one donor. (d) Chronic radiation-
induced apoptosis in fibroblasts measured luminescence generated by caspase 3 cleavage in a population of 
cells as a positive marker of apoptosis. Staurosprorine treated cells were used as positive control. (e) Induction 
of senescence by chronic radiation in primary fibroblasts as measured by GalactoLight assay for senescence-
associated beta-galactosidase activity after 7 days of chronic irradiation at the stated dose rates. The graph shows 
the total activity in a population of cells of the same number, measured in arbitrary units of luminescence (a.u.).
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death, which was indeed somewhat augmented upon irradiation (Fig. 1d), and cellular senescence (as measured 
by staining for senescence-associated beta-galactosidase activity under acidic conditions; Fig. 1e). To address the 
likelihood that these effects were mediated by increased level of reactive oxygen species (ROS), we measured ROS 
levels and found them to be comparable in chronically irradiated and unirradiated control cells (Fig. S1a). This 
would suggest that the effects above were mediated independently of ROS.
Core histone protein levels are reduced by chronic radiation exposure. While using west-
ern immunoblotting to analyse various DDR proteins in un-irradiated and irradiated cells, we observed 
a counter-intuitive change in H2AX phosphorylation. Perhaps surprisingly, the level of γH2AX, which is 
well-documented to be induced by DNA-damaging agents such as radiation, showed a dose-dependent decrease 
in extracts of chronically-irradiated primary fibroblasts (Fig. 2a). Strikingly, analysis of H2AX protein levels 
revealed that this was also associated with a reduction in the overall levels of this protein following chronic 
radiation. This reduction in histone levels is even more noteworthy when the amount of DNA in each loaded 
sample was measured and found to be comparable between samples, with a marginal increase in irradiated ones; 
making the reduction of histones relative to DNA even more stark (Fig. S2a). To determine whether this phe-
nomenon is limited to fibroblasts or to cells from a specific donor, we isolated primary keratinocytes, fibroblasts 
and endothelial cells from another donor and exposed these to chronic radiation at similar dose rates. Again, we 
observed reductions in histone H2AX levels, indicating that the reduction in H2AX was neither cell-type nor 
donor dependent (Fig. 2b). Importantly, these cells were competent with regards to phosphorylating the H2AX 
protein, which they did effectively when they were irradiated with 4 Gy of X-ray. Histone H2AX level reduction 
was also seen with non-skin cells, namely the hTERT-immortalised retinal pigmented epithelium (RPE-1) cell 
line derived from human eye lens (Fig. S2b). Collectively, these studies suggested that H2AX histone levels are 
reduced as a generalised outcome of low dose chronic irradiation.
When we used western immunoblotting to assess the levels of other core histone proteins (H2A, H2A.Z, 
H2B, H3 and H4) and histone H1, we noted that these also displayed general declines in response to chronic 
Figure 2. Chronic γ-radiation reduces histone levels. (a) Western blot analyses of histone H2AX and γH2AX in 
primary fibroblasts exposed to various dose-rates of chronic γ-radiation for 7 days. Cells irradiated with a single 
acute dose of 4 Gy X-ray were included as control. (b) Effect of chronic γ-irradiation on H2AX levels in three 
different isogenic primary cell types from a different donor to that used in (a) at the same dose rates as in (a). 
(c) Immunoblots of other histones in chronically irradiated primary fibroblasts. (d) All significant histone level 
changes detected by SILAC LC-MS/MS protein analyses of samples from primary fibroblasts exposed or mock-
exposed to chronic γ-radiation for 7 days.
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irradiation, albeit to differing extents (Fig. 2c). By contrast, we observed that chronic irradiation led to enhanced 
levels of histone H2A.J, a histone variant recently shown to accumulate specifically in senescent cells33. To extend 
our analyses further, we employed a quantitative protein analysis approach – stable isotope labelling of amino 
acids in cell culture (SILAC) followed by quantitative mass spectrometry analyses – to measure and compare his-
tone levels in irradiated and non-irradiated cells. The results of this analysis (Fig. 2d) confirmed that normalized 
to general protein levels, amounts of all core histones were indeed reduced by irradiation in a dose-dependent 
manner, with histones overall showing, on average, a reduction of 22% with 6 mGy/h and 41% at 20 mGy/h 
chronic radiation for 7 days (Fig. 2d). Importantly, this contrasted with the absence of change in the levels of total 
cellular proteins.
Besides highlighting the effects of chronic radiation on histone levels, SILAC analysis also revealed specific 
reductions in levels of non-histone chromatin-associated proteins such as HMGB and SMC, as well as levels of 
certain proteins involved in DNA replication and cell cycle progression, including MCM2-7, SMC1A/3, and the 
DNA polymerase delta catalytic subunit (POLD1) (Fig. S3 and Table 2). Notably, the levels of HMGB242,43, Lamin 
B1 (LMNB1)44–46 and TMPO47, which have all been reported to be lower in senescent cells were also reduced in 
irradiated cells, in keeping with the rise of cellular senescence as indicated by staining for senescence-associated 
beta-galactosidase activity (Figs. 1e and S4). Consistent with this, increases in levels of p16 (CDKN2A) (1.23 
fold) and p21 (CDKN1A) (1.48 fold), which are often augmented in senescent cells48–50, were also detected in 
chronically-irradiated cells, but do not appear in Fig. S3 as the increases were below the arbitrary threshold of 1.5 
fold change. Other proteins displaying increased levels upon chronic radiation included structural and metabolic 
proteins, a selection of DDR proteins, anti-proliferative proteins and components of the ubiquitin proteasome 
system. Upregulated proteins of particular note were the non-homologous end-joining repair protein XRCC4, 
RRMB2 that catalyses the synthesis of deoxyribonucleotides required for DNA repair and replication, the ubiqui-
tin ligase complex component FBXO44 and the p53-regulated pro-apoptotic PERP protein (Fig. S3).
Histone reductions occur in response to factors inducing cell senescence. If histones were indeed 
reduced in irradiated cells that became senescent, then it would stand to reason that such reductions would also 
be expected to accompany cellular senescence triggered by other stimuli. To this end, we compared histone levels 
of chronically-irradiated cells with those of cells triggered to undergo oncogene-induced senescence (OIS) by Ras 
overexpression, and cells that had undergone replicative senescence. Senescence was confirmed by enlarged cell 
morphology (Fig. 3a), increased p21 and H2A.J levels, and decreased lamin B1 (Fig. 3b). These studies showed 
that the levels of core histones were indeed reduced considerably in all senescent cells regardless of the route by 
which senescence was induced. Similar findings were also obtained with primary keratinocytes (Fig. S5). These 
results thus strongly supported a model in which histone reductions in chronically-irradiated cells was associated 
with these cells having become senescent. An interesting exception to the trend of histone loss was seen with OIS, 
where H2AX reduction was modest and with no rise in H2A.J (Fig. 3b), suggesting that the senescent state of 
these cells was different from radiation-induced and replicative senescence.
Since senescent cells are reportedly present in greater numbers in aged human tissues than in tissues from 
younger individuals51,52, we assessed whether the senescence-associated changes in histone levels that we had 
observed were detectable in vivo. To this end, we isolated primary dermal fibroblasts from human donors rang-
ing in age from 48 to 84 years old and compared their histone levels to those of neonatal donors. We found that 
samples from all older donors, except for one (a 69-year-old individual, who also had a marked increase in p21 
levels), had visibly lower amounts of histones than controls (Fig. 3c), suggesting that the loss of histones observed 
in senescent cells in vitro also occurs in general in vivo upon increasing age.
chronic γ-radiation-induced senescence and histone reduction rely on TP53 but not ATM. To 
characterise the signalling mechanisms underpinning our observations, we examined the potential role of the 
tumour suppressor TP53 (p53) due to its key roles in regulating transcription and senescence in response to DNA 
damage53,54. Thus, we chronically irradiated wild-type, p53 proficient RPE-1 cells alongside derivatives of these 
cells rendered p53 null by CRISPR-Cas9 genome engineering34, at 20 mGy/h for 7 days. As with all other cell 
types analysed, chronically-irradiated parental RPE-1 cells responded by reducing their levels of all core histone 
proteins tested in a manner that was accompanied by increased p21 and decreased Lamin B1 expression (Fig. 4a). 
By contrast, in TP53−/− cells, histone levels were not reduced upon chronic γ-radiation; and in accord with this, 
Pathway ID Pathway description
Observed 
gene count
False 
discovery rate Proteins in pathway
3030 DNA replication 11 1.31E-12 FEN1, MCM2, MCM3, MCM4, MCM5, MCM6, MCM7, POLD1, RFC2, RFC3, RFC4
4110 Cell cycle 10 1.30E-05 CREBBP, MAD2L1, MCM2, MCM3, MCM4, MCM5, MCM6, MCM7, SMC1A, SMC3
3430 DNA mismatch repair 5 0.000123 MSH6, POLD1, RFC2, RFC3, RFC4
3410 DNA base excision repair 5 0.000607 FEN1, HMGB1, MPG, PARP1, POLD1
3420 DNA nucleotide excision repair 4 0.0366 POLD1, RFC2, RFC3, RFC4
Table 2. Pathway analysis of SILAC-based proteomic changes. KEGG (Kyoto Encyclopedia of Genes and 
Genomes) pathway analysis of proteins with >1.5-fold reduction in fibroblasts exposed to 20 mGy/h chronic 
γ-radiation. Analysis was carried out using STRING (https://string-db.org/v10.5). Note that no significant 
pathways were identified for upregulated proteins.
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there was no p21 induction, or reduction of Lamin B1 expression in such cells, highlighting the requirement for 
p53 activity for these responses. p53 is activated by phosphorylation at several sites55. We show considerable phos-
phorylation at serine 15 (Fig. S6a), a site known to be central in DNA-damage response. A small increase in phos-
phorylation is seen at serine 6 (also reported to be activated by genotoxic stress). However, no phosphorylation 
was detected at serine 46 or any other sites probed for. Since many p53-regulated responses require its activation 
by phosphorylation, most notably at serine 15, we investigated the role of ATM, which is the early p53-activating 
kinase in response to DSBs and required for chronic radiation-induced p53 serine 15 phosphorylation (Fig. S6b). 
Not surprisingly, as measured by its increased auto-phosphorylation on serine 1981, the ATM protein was itself 
activated by chronic radiation in both primary fibroblasts and RPE-1 cells (Figs. 4b and S2b). However, when 
RPE-1 cells lacking ATM were exposed to chronic radiation, histone levels were reduced essentially as efficiently 
as in the wild-type ATM+/+ setting (Fig. 4a and S2b), showing that ATM is not essential for the observed reduc-
tions in histone levels in response to chronic irradiation. This was further supported by experiments using pri-
mary fibroblasts exposed to chronic radiation in the presence of the ATM inhibitor KU5593356 for 24 h prior to 
harvesting or for the entire duration of the 7-day exposure (Figs. S2c). While it did at first appear surprising that 
p53 but not ATM was required for reducing histone levels in response to chronic irradiation, we noted that p53 
protein was upregulated, with concomitant increase of its downstream target p21, in chronically irradiated RPE-1 
cells independently of ATM status (Fig. 4). While there may be other explanations, these findings suggested that 
in ATM’s absence, ATR and/or DNA-PK might serve to activate p53 in response to chronic irradiation. Whatever 
the case, it was clear from the reduced levels of lamin B1 and increased levels of p21 (and changes in cell morphol-
ogy), that unlike the situation with TP53−/− cells, ATM−/− cells were not impeded from becoming senescent in 
response to chronic irradiation. Consistent with the previous observation that chronic radiation does not increase 
ROS levels (Fig. S1a), the loss of histones was not affected by inhibiting ROS (Fig. S1b).
Histone reductions are not abrogated by proteasome or autophagy inhibition. We next pro-
ceeded to investigate how histone levels are reduced in chronically-irradiated cells. As the two major mecha-
nisms of protein degradation in cells occur via the proteasomal or lysosomal (autophagy) pathways, we examined 
the potential involvement of these by using the chemicals MG132 or chloroquine that inhibit these two path-
ways, respectively. As seen in Fig. 5a, H2AX protein levels were augmented by these two inhibitors even in 
un-irradiated cells, indicating the involvement of both the proteasomal and lysosomal pathways in maintaining 
Figure 3. Reduced histone levels in senescent cells is induced in vitro by different means, and in vivo from 
aged donors. (a) Phase-contrast images of primary fibroblasts induced into senescence by chronic γ-radiation, 
oncogene over-expression or exhaustive replication (replicative senescence), and DNA damage from a single 
acute 4 Gy X-ray dose at an early time-point (1 hour) as a control for DNA damage without senescence. Scale 
bars 200 µm. (b) Western immunoblot analyses of histones in fibroblasts described in (a). (c) Histone levels in 
dermal fibroblasts isolated from human neonatal (age 0, donors a and b) and adult donors.
9Scientific RepoRtS |         (2020) 10:2200  | https://doi.org/10.1038/s41598-020-59163-4
www.nature.com/scientificreportswww.nature.com/scientificreports/
H2AX levels under steady-state conditions of normal cell growth in culture. Perhaps surprisingly however, this 
was not the case for other histones, the levels of which were broadly unaffected by MG132 or chloroquine treat-
ment. Regardless of these differences between H2AX and core histones, the levels of H2AX and the other histones 
declined under chronic radiation conditions, whether cells were grown in the presence of MG132 or chloroquine 
(Fig. 5a). Collectively, these data indicated that reduction of histone levels under chronic irradiation conditions 
does not primarily reflect their destruction by proteasomal or lysosomal proteolytic processes. This is a departure 
from conclusions reached through previous studies on histone loss in senescent cells57,58.
chronic radiation reduces histone transcript levels. To further explore the mechanism of histone 
reductions upon chronic irradiation, we considered that this might reflect reduced histone gene transcript levels 
(via reduced transcription, RNA processing and/or mRNA stability) and ensuing histone protein synthesis. We 
investigated this by analysing differential gene expression in primary fibroblasts exposed to 6 mGy/h or 20 mGy/h 
of γ-radiation for 7 days. By RNA sequencing (RNA-seq) analyses, we found irradiation-dose dependent reduc-
tions in the levels of all significantly measurable histone transcripts (Fig. 5b). To independently validate these 
RNA-seq results, we specifically measured levels of selected histone transcripts using qRT-PCR, which confirmed 
substantial reductions in histone transcripts in response to chronic radiation (Fig. 5c; these data also revealed 
increased mRNA levels of histone variant H2A.J, whose protein was recently shown to accumulate specifically in 
senescent human cells33, which we also observed in our experiments, Figs. 2c and 3b, although its p-value in the 
RNA-seq analyses was above that of the set limit so does not appear in final data). These findings thus strongly 
supported reduced histone gene transcription and/or mRNA stability as being the primary cause of reduced his-
tone levels in chronically-irradiated cells.
Chronic irradiation leads to chromatin decompaction and elevated global RNA synthesis. In 
addition to compacting and packaging of DNA, histones confer higher-order chromatin structure that is pivotal 
for proper regulation of gene expression. This feature of histones is modulated through modifications such as 
acetylation and phosphorylation, which in part alter the tightness by which DNA is wound around nucleosomes, 
and in turn influence access and binding by transcription factors16,59. As we found that histone levels are substan-
tially reduced in chronically irradiated cells that have become senescent, we speculated that this might impact on 
genome compaction and hence transcription. Indeed, when we stained cells with DAPI this revealed that chronic 
irradiation for 7 days led to a dose-dependent increase in nuclear area (Fig. 6a). As DAPI specifically stains DNA, 
the increased nuclear area relative to unirradiated cells is indicative of potential increase of nuclear size and 
therefore looser packaging of chromatin60, which would be in keeping with histone reductions. To ascertain the 
impact of this less compacted DNA on transcription, we measured global RNA synthesis by using the intensity of 
fluorescent 5-ethynyl uridine (EU) pulse-labelled RNA. This analysis indicated a radiation-dose dependent rise 
in the amount of overall transcript levels, in both fibroblasts and keratinocytes (Fig. 6b), supporting the notion 
that reduced histone levels reduce DNA compaction and increase overall RNA synthesis. Clearly, this overall 
rise in transcript levels does not preclude reduction in the levels of some specific transcripts. Indeed, quantita-
tive RNA sequencing analyses revealed that of the 21 genes whose mRNA levels were most significantly altered 
Figure 4. p53 but not ATM is required for chronic γ-radiation-induced histone reductions. (a) Western blots 
of histone proteins in wild-type, TP53−/− and ATM−/− RPE-1 cells following exposures to 20 mGy/h chronic 
radiation for 7 days. (b) ATM activation, as shown by auto-phosphorylation on S1981, in response to chronic 
radiation in primary fibroblasts.
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by irradiation at 6 mGy/h, 8 of them were up-regulated while the remaining were reduced (Table 3). Chronic 
irradiation at 20 mGy/h elicited differences in mRNA levels in 304 genes, of which 135 were augmented and the 
remaining were decreased (Fig. S7).
One of the ways that senescent cells influence their environment, and tissue beyond, is through the produc-
tion and release of proteins related to the senescence-associated secretory phenotype (SASPs) and subsequent 
inflammatory response61,62. At the level of RNA, gene expression associated with SASP (including growth fac-
tors FGF2/9, matrix metallopeptidases (MMPs) and collagens) were augmented in chronically-irradiated cells 
(Table 4). Curiously expression of IL-6, which is a prominent SASP factor, was actually reduced, perhaps reflect-
ing the often-noted lack of consistency between senescent phenotypes and markers44,63,64. At the protein level, 
SILAC identified increases of other SASP proteases and regulators, including metalloproteinases MMP1/2/11/14, 
TIMP1/2/3, SERPINE1 and Cathepsin B (CSTB), in chronically-irradiated cells (Table 4), indicating the potential 
involvement of inflammatory processes.
Discussion
Although many aspects of cellular responses to radiation-induced DNA damage have been well-characterised, 
there remain areas such as chronic radiation effects on cells, that are yet to be fully explored and understood. This 
report demonstrates that the current understanding of cellular responses to IR, gained from studies of acute radi-
ation, would not have predicted the effect of chronic radiation on very fundamental cellular characteristics such 
as cell proliferation and senescence. According to the standard model of cellular responses to radiation, DNA 
breaks – and in some cases even a single DSB – would trigger a temporary cell cycle arrest, allowing repair before 
continued progression through the cell cycle65–67. While this may understandably retard cell division to some 
extent, we did not expect it to trigger substantial cellular senescence because in our experiments, IR was delivered 
at doses that are estimated to inflict fewer than a single DSB per cell each hour. This very low and infrequent 
estimated number of DSBs was confirmed using 53BP1 foci as a surrogate measurement of DSB formation in 
chronically-irradiated cells in culture. Although acute radiation-induced cellular senescence has been previously 
observed and documented18, it was assumed to occur when cells fail to repair their damaged DNA. This can hap-
pen if the DNA damage is too complex for straightforward repair or if the breaks are too numerous for the cells 
to cope. In view of low radiation doses such as we used in our studies, the latter is unlikely. Regarding the former, 
IR can indeed cause clustered DNA damage that can be a mixture of DSBs, single-strand breaks and base dam-
age68,69, which can be difficult to repair. If this were the case in our studies however, the number of DSB foci would 
be expected to accumulate beyond the expected steady-state number, which was not the case. Our findings with 
Figure 5. Reduction of histone levels in chronically irradiated cells occurs mainly though reduced 
transcription, not protein degradation. (a) Effect of inhibiting the protein degradation capability in fibroblasts 
exposed to chronic radiation for 7 days. Proteasome inhibition (5 µM MG132 for 24 h) or lysosomal autophagy 
inhibition (10 µM chloroquine for 24 h) of fibroblasts exposed to chronic γ-radiation for 7 days. (b) Differential 
expression of histone gene transcripts from RNA-seq analyses of primary fibroblasts after 7 days exposure to 20 
mGy/h chronic γ-radiation with changes greater than 1.5-fold and p < 0.01. (c) Changes in core histone levels in 
fibroblasts as measured by qRT-PCR after 7 days exposure to the same radiation conditions as in (b).
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Figure 6. Chronic γ-radiation increases nuclear size and global RNA synthesis. (a) Nuclei of fibroblasts 
exposed to chronic γ-radiation for 7 days, stained with DAPI. All images were acquired by fluorescent 
microscopy with 10X objective under similar conditions and quantified by automated software detection and 
nuclear area calculated for >1000 cells. (b) Global RNA synthesis in primary keratinocytes and fibroblasts; 
detected by pulse labelling with Alexa 488-labelled EU and ensuing measurement of average fluorescence 
intensity per cell. *Is p < 0.1, *** is p < 0.001 relative to un-irradiated samples.
Down-regulated by 6 mGy/h and 20 mGy/h Fold-change
EGR1 Early growth response 1 0.266
PTGS2 Prostaglandin-endoperoxide synthase 2 0.394
FCGBP Fc fragment of IgG binding protein 0.409
IL6 Interleukin 6 0.530
CENPU Centromere protein U 0.540
CTGF Connective tissue growth factor 0.541
CYR61 Cysteine rich angiogenic inducer 61 0.561
CCNA2 Cyclin A2 0.584
CENPE Centromere protein E 0.602
KIF20A Kinesin family member 20A 0.609
KIF11 Kinesin family member 11 0.617
TOP2A Topoisomerase (DNA) II alpha 0.622
Up-regulated by 6 mGy/h and 20 mGy/h Fold-change
PSG2 Pregnancy specific beta-1-glycoprotein 2 3.436
BTG2 BTG anti-proliferation factor 2 2.378
SPATA18 Spermatogenesis associated 18 2.303
DDIT4 DNA damage inducible transcript 4 2.141
DDB2 Damage specific DNA binding protein 2 1.829
HMOX1 Heme oxygenase 1 1.822
PAPPA Pappalysin 1 1.792
PPP1R3C Protein phosphatase 1 regulatory subunit 3C 1.594
Table 3. RNA-seq differential gene expression. List of significant transcript changes (>1.5-fold change, 
p < 0.01) as identified by RNA-seq analyses of primary fibroblasts chronically irradiated at either 6 or 20 mGy/h 
for 7 days.
1 2Scientific RepoRtS |         (2020) 10:2200  | https://doi.org/10.1038/s41598-020-59163-4
www.nature.com/scientificreportswww.nature.com/scientificreports/
chronic low-dose irradiation bring into focus the potential clinical effects of chronic low dose radiation, especially 
regarding pathologies that are promoted by or exacerbated by senescent cells. Although senescence has been 
identified in cellular models as a result of chronic radiation70–72, any potential effects in humans or animal models 
may have previously escaped notice as senescent cells accumulate naturally in the body with age52,73. Hence any 
additional contribution of chronic low dose radiation may not be immediately obvious and appreciated.
A key finding from our studies is that the amounts of H2AX and core histones are reduced in 
chronically-irradiated cells. Histone loss in yeast cells treated with zeocin or acute high dose radiation was 
Fold change 
6 mGy/h
Fold change 
20 mGy/h
SILAC (protein) or 
RNA-seq (gene)
Reported direction of 
change Reference
IL-6 0.53022 0.4969 RNA only UP 1
FGF2 — 1.74073 RNA Growth factors, UP (1)
FGF2 0.992 1.153 SILAC Growth factors, UP (1)
FGF9 — 1.54853 RNA Growth factors, UP (1)
IGFBP5 1.317 2.284 SILAC IGFBP family, UP 1
MMP1 3.749 3.147 SILAC UP 1
MMP2 1.970 1.883 SILAC MMP family, UP (1), 2
MMP2 — 3.9616 RNA MMP family, UP (1), 2
MMP3 — 2.00881 RNA UP 1
MMP11 2.462 3.485 SILAC MMP family, UP (1)
MMP14 1.648 1.550 SILAC MMP family, UP (1)
TIMP1 1.173 1.337 SILAC DOWN 1, 2
TIMP2 2.289 1.830 SILAC UP 1
TIMP3 1.102 1.595 SILAC Other TIMPs altered (1)
SERPINE1 1.364 1.422 SILAC UP (PAI-1) 1, 2, 3
CTSB 1.115 1.399 SILAC UP 1, 2
CTSD — 1.49723 RNA Altered 2
FN1 1.383 2.531 SILAC UP (fibronectin) 1,2
COL2A1 — 13.659 SILAC Collagens altered 1
COL13A1 0.653 2.033 SILAC Collagens altered 1
COL4A2 1.781 1.339 SILAC Collagens altered 1
COL11A1 0.496 1.547 SILAC Collagens altered 1
COL8A1 0.850 1.168 SILAC Collagens altered 1
COL4A3BP 1.358 1.449 SILAC Collagens altered 1
COL6A2 1.120 1.162 SILAC Collagens altered 1
COL6A3 0.979 1.004 SILAC Collagens altered 1
COL3A1 1.217 1.332 SILAC Collagens altered 1, 2
COL1A2 1.239 1.565 SILAC Collagens altered 1
COL6A2 — 4.21427 RNA Collagens altered 1
COL21A1 — 0.51108 RNA Collagens altered 1
COL14A1 — 0.60807 RNA Collagens altered 1
COL4A4 — 2.26572 RNA Collagens altered 1
LBR 0.760 0.535 SILAC Laminins altered 1
TMPO 0.690 0.461 SILAC Laminins altered 1
LMNB1 0.789 0.590 SILAC Laminins altered 1
TMPO 0.786 0.558 SILAC Laminins altered 1
LAMB1 0.916 0.669 SILAC Laminins altered 1
LMNB2 0.908 0.767 SILAC Laminins altered 1
LAMA2 1.063 0.919 SILAC Laminins altered 1
LMNA 1.075 1.040 SILAC Laminins altered 1
LAMA5 1.148 0.846 SILAC Laminins altered 1
LAMB2 0.969 0.957 SILAC Laminins altered 1
LAMA4 0.954 0.954 SILAC Laminins altered 1
LMNA 1.063 1.029 SILAC Laminins altered 1
LAMA1 1.654 1.198 SILAC Laminins altered 1
LAMC1 1.087 1.069 SILAC Laminins altered 1
Table 4. SASP transcript changes with chronic radiation. 1. Coppe et al.61; 2. Özcan et al.81; 3. Vaughan et al.82; 
(pathway, not direction).
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reported by Hauer et al.57. They demonstrated this to be due to proteolytic degradation of the histone proteins; 
which is also the route by which histone levels were reportedly reduced in Jun-deficient mouse fibroblasts that 
were exposed to high levels of reactive oxygen species74. Our findings suggest that chronically-irradiated cells 
employ a different means to the same end: namely by reducing histone gene mRNA levels. There are various 
factors that could explain this apparent difference in regulatory mechanism between the various studies, ranging 
from species used, genetic modification, the nature of DNA damaging agent and/or dosing schedule; none of 
which can be singled out without empirical testing. A feature deserving more attention in future studies will be 
to establish precisely how histone gene transcripts become reduced in response to chronic radiation, for example 
via decreased transcription, reduced transcript stability, or both. Since most histone gene expression is usually 
up-regulated during S-phase75,76, it is likely that a contributing factor to histone transcript reductions we observe 
upon chronic irradiation could reflect chronically irradiated cells having lower S-phase indices because they have 
arrested cell cycle or entered senescence. However, the promoter of H2AX is not cell cycle-responsive76 and yet 
Fig. 5 shows its transcript levels declined in concert with other histones in response to chronic radiation. We also 
demonstrate the consistent loss of H2AX protein, which does not fluctuate with cell cycle but has been shown to 
be stabilised by DNA-damage77. Identifying how the multiple histone transcript levels are co-ordinately regulated 
in such settings could potentially uncover a master regulator(s) that actively suppresses histone gene expression 
in senescent cells.
Independent of the mechanism, reduction of histone levels has a clear predicted outcome – increased relax-
ation of chromatin and a concomitant general increase in transcription, both of which we indeed detected in 
chronically-irradiated cell populations (Fig. 6). It is now established that senescent cells are not benign and, in 
many circumstances, are actively destructive78,79. This is in part connected to them producing and secreting pro-
teins, especially pro-inflammatory ones that can cause the dysfunction of surrounding cells and tissues, plus those 
further away if secreted into the bloodstream62. We have indeed detected chronic radiation-induced increased 
transcripts for some SASPs as listed in Table 4, although we have also noted a reduction of IL-6 transcripts. 
This is, however, consistent because IL-6 is not part of the Skin Ageing-Associated Secreted Proteins (SAASP)80 
which, as the name suggests, are proteins secreted by ageing human dermal fibroblasts, the very cells used here. 
In summary, our results reveal histone reductions associated with cellular senescence as an effect of continuous 
exposure to low doses of ionising radiation that may have wider implications for ageing and the incidence of 
specific pathologies.
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